Subject and disease characteristics (safety population)
| Subject characteristic | Safety population (N=38) | |
| Age at screening (years) | ||
| Mean (SD) | 52.4 (15.80) | |
| Min, Max | 22, 77 | |
| Sex, n (%) | ||
| Male | 13 (34.2%) | |
| Female | 25 (65.8%) | |
| Race/Ethnicity, n (%) | ||
| White—not Hispanic or Latino | 26 (68.4%) | |
| Black/African American—not Hispanic or Latino | 7 (18.4%) | |
| White—Hispanic or Latino | 5 (13.2%) | |
| Disease characteristic (N=38) | Study eye* | Fellow eye† |
| Uveitis type, n (%) | ||
| Anterior uveitis | 12 (31.6%) | 10 (26.3%) |
| Intermediate uveitis | 15 (39.5%) | 12 (31.6%) |
| Posterior uveitis | 10 (26.3%) | 8 (21.1%) |
| Panuveitis | 10 (26.3%) | 7 (18.4%) |
| Uveitis onset, n (%) | ||
| Sudden | 16 (42.1%) | 4 (10.5%) |
| Insidious | 20 (52.6%) | 10 (26.5%) |
| Uveitis duration, n (%) | ||
| Limited (≤3 months duration) | 5 (13.2%) | 3 (7.9%) |
| Persistent (>3 months duration) | 31 (81.6%) | 11 (28.9%) |
| Uveitis course, n (%) | ||
| Acute | 1 (2.6%) | 1 (2.6%) |
| Recurrent | 11 (28.9%) | 1 (2.6%) |
| Chronic | 24 (63.2%) | 12 (31.6%) |
| Aetiology of uveitis, n (%) | ||
| Idiopathic or not specified | 21 (55.3%) | 15 (39.5%) |
| Sarcoidosis | 8 (21.1%) | 8 (21.1%) |
| HLA-B27 related | 3 (7.9%) | 2 (5.3%) |
| Reactive arthritis | 2 (5.3%) | 2 (5.3%) |
| Vogt-Koyanagi-Harada syndrome | 1 (2.6%) | 1 (2.6%) |
| Birdshot retinochoroidopathy | 3 (7.9%) | 3 (7.9%) |
*Two study eyes were not assessed for disease characteristics.
†Thirty-one out of 38 fellow eyes were diagnosed with uveitis.